T2 Biosystms Inc
Diagnostics & Research
Healthcare
TTOO
80.92 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
6.24
52 week high
26.85
high
6.27
52 week low
1.35
low
5.36
growth
165.20 %
previous Close
6.28
P/E ratio
market cap
8.54 M
div yield
0
usd
Jun 2023
qoq
revenue
1.96 M
-5.49 %
net incoming
-6.35 M
68.33 %
eps
0.00 %
93.94 %
eps surprise
70.37 %
net profit margin
-323.17 %
641.00 %
operating incoming
-13.05 M
4.65 %
net change in cash
5.97 M
592.33 %
cash on hand
16.08 M
58.98 %
cost of revenue
4.87 M
21.88 %
top top